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Molecular Analysis in the management of Congenital Adrenal Hyperplasia (CAH) and
Ambiguous Genitalia
MN. Isa l , Y.K. Muhamad ', Fuziah MZ2, Rus Anida AJ, M. Ros Sidek l ,
S.F. Ramli', N. Adami
'Human Genome Centre,
2Department of Paediatrics, School of Medicine,
Universiti Sains Malaysia,
16150 Kubang Kerian,
Kelantan, Malaysia.
3Department of Paediatrics,
Hospital Kota Bharu,
15586 Kota Bharu,
Kelantan, Malaysia.
* Address correspondence and reprint request to
Dr. Fuziah Md. Zain,
Department of Paedia.trics, Health Campus,
Universiti Sains Malaysia,
16150 Kubang Kerian,
Kelantan, Malaysia.
E-mail: fuziah@kb.usm.my
Patients presenting with ambiguous genitalia (AG) often pose a dilemma to the attending
clinicians with regard to sex assignmcnt. To avoid gender confusion in later life, it is
important to recognize the underlying cause, initiate treatment and appropriate sex
assignment as soon as possible. We present 3 case reports to illustrate the use of
fluorescence in-situ hybridization (FISH), chromosome karyotyping and SRY gene
identification in the evaluatiop of patients with AG. Current hormonal and imaging
studies for sex determination could be complementcd by the application of chromosomal
and molecular genetic studies which provide rapid and reliable genetic diagnosis. Delay
in diagnosis ~l'nd treatment may result in death due to undiagnosed adrenal crisis in case
of congenital adrenal hyperplasia (CAH) and wrong sex assignment with its tragic
consequences. Molecular study and detcrmination of the SRY gene are additional tools
for the investigations of patients with AG and intersex disorders.
Key words: congenital adrenal hyperplasia (CAl-I), ambiguous genitalia (AG), sex
determinaliol1 region-Y (SRY),
INTRODUCTION
The issue of gender assignment causes anxiety
and the problem of acceptance on the part of the
parents. Patients with ambiguous genitalia should
be investig~tedin order to understand the underlying
pathology and to provide a rational approach to
management and sex assignment. Diagnosis is aided
by hormonal, ~maging studies and genetic
information. Current clinical and hormonal
investigation protocols for sex determination can be
enhanced by the application of chromosomal and
molecular genetic studies using SRY gene.
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The word ambiguous means indeterminate,
doubtful or uncertain. The term ambiguous genitalia
(AG) describe external genitalia that do not conform
to that of male or female. This would include severe
hypospadias with or without palpable gonads or
micropenis!. Other description for such
abnormalities include enlarged phallus/clitoris,
scrotalisation of the labioscrotal folds, partial or
complete fusion of the labioscrotal folds, chordee,
urogenital sinus and blind vaginal pouch.
The problem in the management of a baby with
AG is not only sex determination and appropriate
assignment, it is also prompt recognition of underlying
Iv/uleet/lllr AIIlIlyst.\· ill the /IIWUlM"lIIt'llt (4 ('uIIgt'lit/lI/ Adrenal f/yper/J/llsill (CAH) lind Ambiguous GeJliwJiu
medical emergencies that may be associated. The
• clinician must must be quick to detect life-threatening
adrenal crisis in case of salt losing congenital adrenal
hyperplasia (CAHf, and initiate immediate
investigations and managementJ·7
The initial treatment goals include firstly,
determination of the appropriate sex of rearing as quickly
as possible. Secondly, establishment of definitive
diagnosis, which may take longer to achieve. To avoid
gender identification crisis, social, personality and
religious problems during adulthood, follow up care and
management is needed to ensure physical and
psychological development concordant with the assigned
sex4 •
Availability of specitic hormonal investigation
is limited. Conventionally, genetic sex is determined by
chromQsome karyotyping. The result is generally
available within one month but a preliminary report may
be available within a week. Currently new methods are
available using molecular technology such as
fluorescence in-situ hybridization (FISH) using the X
(Figure 7) and Y (Figure 8) probes to identify the types
ofchromatin present. Identification of SRY gene (Figure
9) is another of these new molecular techniques 4.
Figure 7: Microphotography of FISH technicjue using
the chromosome X probe (pDMX I) 011 interjihllse cell,
arrow shows 2 signals of the chromosome X
The SRY gene is the testis-determining gene
located on the short arm of the Y chromosome. It
initiates a cascade of events that ultimately lead to
testis differentiation. Studies sh~ed that SRY gene
in an individual indicates the presence of testicular
tissues. The use of the SRY gene testing as a tool in
complementing hormonal, imaging studies in the
evaluation of children with AG is helpful. The result
can be obtained in less than a week 4. Decision on
gender assignment and registration of birth of baby
can be made without much delay.
Figure 8: Microphotography of FISH technique using
pH Y.I probe. Arrow sholVs Ihe ipecific Y chromosome.
Figure 9: Photograph ofamplified mlliliplex PCR prodlli;ts
IIsing X. Y chromosome lIlId SRY gene ipecific PCR primers.
M- IDO bp DNA ladder (marker)
I - DNA slimpIe jf-om 46 XY with the presence ofSRY gene
(273 bp)
2 - DNA. .\'ulJlple!rwn 46 XX in the ahsence of the SRY gene
3 - DNA .\'((lJIple./f'ol1l 46 XY with the absence ofSRY gene
4 - Negwive control (withollt DNA)
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RESULTS
METHODS
OBJECTIVE
Patient 1, presented to Hospital Kota Bharu
(HKB) at 10 weeks of age with intermittent vomiting
Three patients were referred to Hospital Kola
Bharu (HKB) and Hospital Universiti Sains Malaysia
(HUSM) for further management of ambiguous
genitalia. Blood specimen of3-5 ml from the patients
with ambiguous genitalia was collected in sodium
EDTA or lithium heparin container. Blood was
cultured for metaphase cells for cytogenetic and
FISH according to the standard protocol. Genomic
DNA was extracted and subjected to the PCR
analysis of SRY gene method5. 6.
The aim of the study is to apply the molecular
studies to complement the investigations for the
genetic assignment of patients with ambiguous
genitalia by presenting 3 case reports.
and failure to thrive since birth. The patient, a product
ora non-consanguineous marriage was born full term by
spontaneous vaginal delivery at a district hospital with a
birth weight of 2.8 kg (25-50Ih percentile), length 56 cm
(>97Ih percentile) and head circumference 33 cm (10-
251h percentile). She is the youngest of 5 siblings and the
eldest sibling who was a boy died at 17 days old of an
unknown cause. On examination she was mildly
dehydrated with a weight of2.8 kg «3rd percentile). She
was afebrile and the blood pressure was 60/40 mmHg.
No other abnormalities were detected apart from AG
with a prominent phallus measuring 2 cm. No gonads or
rugae were noted at the labioscrotal folds, which was
not hyperpigmented. There was a single orifice at the
base of the phallus. The baby was regi"tered as a girl by
the parents as they were not aware of the ambiguity of
the external genitalia at that particular time.
The initial electrolytes showed
hyponatraemia, hyperkalaemia, increased blood urea
and metabolic acidosis (Table I). A diagnosis of salt-
losing CAH was made and she was started on
glucocorticoids and mineralocorticoids. The
hormonal investigations showed that 17-
hydroxyprogesterone (17 -OHP) and aldosterone
were elevated with normal cortisol level (Table I).
Th" m~l~lts of hormon(ll ;nvf>stigntirln of the 3 pat;el1fs are tabulated as follows:
Tests Nonnal Rans;1;e Patient 1 Patient 2 .- Patient 3
Sodium 135-150 mmol/L 92 118 138+
Potassium 3.5 - 5.0 mmol/L 7.4 8.2 5.5+
Blood urea 1.4 - 6.8 mmollL 11.0 NA 5.7+
Standard 18 - 25 mmoi/L 12.0 NA NAbicarbonate (HC03 ) •
>20 nglml 33.2 nglml 2.8 nmollL++17-0HP 3 mth-5 yr: up to
1.1 ng/ml «0.7-2.5) (nonnal for age)
484 nmollL 67 nmol/L+Cortisol NA (am: 221-690(am: 139-501) pm : 110-345)
ACTH NO 50.7 pglml NO(N: <37)
<20 ngldl 3.0 nmol/LTestosterone NA adult fem.ale:(no reference) 0.9-2.8
>3,300 pmollL 1,400 pmollL+
Aldosterone (111-860 NA erect: 1 10-860
pmol/L) supine: 30-440
Plasm.a renin 72.0 nglml/h+
activity NA NA erect: 1.3-4.0
supine: 0.1-2.4
Karyotyping 46,XX 46,XX 46,XX
SRY gene Not present Not present Not present
Uterus. Bilateral
Ultrasou~d Uterus and
pelvi-calyceal
ovaries Uterus system dilatation.Mildly distended
bladder.
Genitogram Figure 3 Figure 5 ND
Table 1: **Results ohtain.ed prior to honl1on.al therapy * Patil'l1t was 0/1 hannonal therapy
!11
NA: not available ND: not done
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On follow-up she had normal weight gain and
serum electrolytes. At 2 years of age there was
evidence of under treatment as there was an
acceleration in growth velocity. Bone age was
reported as between 6 to 9 months old. The dose of
cortisone acetate was increased to 10 mg/m2/day and
5 months later, it was further increased to 30 mg/m2/
day. Serum 17-0HP was monitored. Her bone age
at 6 years old was reported as 5 years and 10 months.
The blood pressure was normal except for a
borderline reading of 120170 mm Hg at 4 6/12 and
56/12 years old.
At 6 5/12 years old, she was admitted to our
centre for fever, vomiting and 3 episodes of fits.
Patient had hypotension and needed assisted
ventilation. She was managed as adrenal crisis and
meningitis I (Figure 1). Her height was 110 em (25-
50th percentile), weight 20 kg (75-90th percentile).
She appeared muscular with hypertrophied clitoris
measuring 3.2 cm (Figure 2). During the course of
admission she was noted to have hypertension that
was initially attributed to the high dose of
intravenous hydrocortisone.
An echocardiography performed revealed a
thickened left ventricular wall with reduced
contractility. Patient was thought to have a long-
standing hypertension. She was started on
antihypertensives and digoxin. Fludrocortisone was
discontinued. The results of molecular studies
showed a genotype of 46, XX and SRY gene was
not lJresent. Ultrasound of the abdomen and pelvis
showed female internal reproductive system.
On follow-up, the serum electrolytes without
mineralocorticoid therapy were normal. Genitogram
of patient I (Figure 3) showed opacification of both
the bladder and vagina. The perineal opening
continued into a short segment urogenital sinus that
bifurcated just at the level of inferior pubic rami.
Clitoroplasty and vaginoplasty were performed.
Patient was maintained on glucocor~icoidsat a dose
of 16 mg/m2/day and her blood pressure readings
were normal.
Patient 2, was born full term by spontaneous
vaginal delivery at a district hospital with a birth
weight of2.7 kg (25'h percentile). He was registered
as a boy at birth. On day 6 of life, he was referred to
HKB for severe neonatal jaundice that required
intensive phototherapy. Patient is the younger of 2
siblings and a product of a consanguineous marriage.
During hospitalization, it was noted that
patient had an AG described as a prominent phallus,
hyperpigmented labioscrotal folds with a single
orifice at the base of the phallus and gonads were
not palpable. Initial serum electrolytes showed severe
Figure 1: CT scan of patient 1: Presence of meningeal
enhancement on the right temporo-parietat region
suggestive of meningitis.
Figure 2: External genitalia ofpatient 1: Enlarged clitoris
of3.2 em. •
Figure 3: Genitogrum ofpatient 1: The urinary bladder
(UBD) and vagina (V) are opacified with a single perineal
upening.
hyponatraemia and hyperkalaemia, Based on the
clinical picture and electrolyte abnormality a
diagnosis of CAH was made. Patient was started on
glucocorticoid and mineralocorticoid. Hormonal
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Figure 6, Ultrasound ofthe kidneys o.fpatient 3 showing
hilalent! pelvicalyceal system dilatalio/! (circle).
Figure 4, US pelvis ofpatiellt 2 showing the uterus (UT).
urinary bladder (UBD)
Figure 5, Genilogram ofpatient 2, The urinary bladder
(UBD) was fi.lled with contrast and normal in outline..
serum testosterone level was sLightly elevated according
to the adult female range. Serum 17-0HP level before
commencement of hormonal therapy was normal.
Aldosterone and plasma renin activity obtained when
patient was on mineralocorticoid therapy were still
elevated for age. Molecular studies confinned that patient's
karyotype wa~ 46 XX, SRY gene was not present.
------ ----
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investigations showed elevated 17-0HP and ACTH
level. The testosterone was <20 ng/dl. Chromosome
analysis showed a 46, XX karyotype and SRY gene
was not present. The ultrasound of abdomen and
pelvis revealed the presence of a uterus (Figure 4)
and the genitogram demonstrated a normal urinary
bladder (Figure 5). Patient was re-assigned as female
at the age of 6 months. Patient was first seen in our
centre at the age of 9 months. Weight was 6.4 kg
(I 0-25th percentile), height 64.3 cm (50th percentile)
and head circumference 42.5cm (25-50th percentile).
The external genitalia was hyperpigmented over the
labia majora. Gonads were not palpable. The clitoris
measured 2.5 cm with a single orifice at its base.
Subsequent 17-0HP and testosterone level was
su'ppressed while on treatment. Further surgical
intervention was planned.
Patient 3 was referred to our centre on Day 13
of life for further management of AG. Patient was born
full term by spontaneous vaginal delivery at a private
hospital with a birth weight of 3.1 kg (75'h percentile).
The parents are non-consanguineous and patient has
an elder sister who is healthy. Mother had a
miscarriage for the first pregnancy. On Day 5 of life
patient had hyponatraemia and hyperkaJaemia. Based
on the clinical finding of ambiguous genitalia and
typical electrolyte changes, diagnosis of CAH was
made. Treatment was started with glucocorticoids and
mineraJocorticoids after performing some hormonal
investigations. Ultrasound of the abdomen revealed
bilateral large adrenal glands and presence of a uterus.
On examination, the weight was 3.3 kg (75-
90'h percentile) and length 52 cm (>97'h percentile).
Baby had oral thrush and.greenish discharge from the
umbilicus. The external genitalia appeared feminine
with a clitoris measuring 0.9 cm in length. There was
slight hyperpigmentation and scrotalisation of the
medial aspect of the labia majora. Gonads were not
palpable. There was no fusion of the labia minora and
there were 2 slit-like orifices seen representing the
urethra and vaginal orifices. The electrolytes while
patient was on hormonal therapy showed normal
- serum sodium and blood urea level with slight
hyperkalaemia (Table 1).
Patient was maintained on glucocorticoids and
mineralocorticoids pending results of hormonal
investigations. A repeat ultrasound examination at our
centre showed presence of uterus, normal suprarenal
glands, dilatation of the pelvicalyceal system of both
kidneys (Figure~) and mildly distended urinary
bladder. The urine examination was normal and no
organisms were cultured. Umbilical swab showed a
mixed growth of Gram negative organism and the full
blood picture showed reactive thrombocytosis. The
I_..~
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Based on the results of in vestigations, the
glucocorticoids and mineralocorticoids were gradually
tapered and discontinued respectively. On follow-up,
the clitoris size normalized and the rugation of the
medial aspect of the labia majora disappeared.
Subsequent electrolytes values were within the normal
range. A repeat ultrasound of the urinary system one
month .later was reported as normal.
DISCUSSION
The presentation of the 3 patients illustrates
the problem encountered in managing AG/CAH. The
diagnosis of CAH has to be suspected from the
physical appearance, symptoms or positive family
history. Investigations have to be done to confirm
the diagnosis ofCAH and the genetic sex of the child.
Delay in diagnosis and treatment of CAH lead to
the development of life threatening adrenal crisis as
in patients I and 2. Wrong gender assignment has
tragic consequences8• In a newborn baby with AG
urgent investigations are warranted. Sex assignment
should not be attempted based on appearance of
external genitalia. Patient 2 was wrongly assigned
as male and family had to suffer the psychological
trauma of re-assignment as temale at the age or b
months. Genetic sex of the 3 patients were
subsequently established using karyotyping and
determination of SRY gene9.
Congenital adrenal hyperplasia was suspected
in patient 3 based on some ambiguity of the external
genitalia and electrolyte imbalances at the initial
presentation. After the relevant hormonal
investigations were taken, patient was started on
glucocorticoids and mineralocorticoids by the
attending paediatrician so as to prevent possible
adrenal crisis. There was elevated aldosterone level
and plasma renin activity despite treatment. The full
blood picture showed thrombocytosis and an umbilical
swab showed a mixed growth of gram negative bacilli
suggestive of possible infection. Urosepsis was ruled
out from the urine examination and culture. In view
of bilateral pelvicalyceal system dilatation and mildly
distended urinary bladder, a vesicoureteric reflux and
urinary tract infection were considered as possible
causes. However we could not confirm vesicoureteric
reflux on repeat ultrasound a month from presentation.
Infection probably causes unresponsiveness of the
distal renal tubules to aldo~terone, a condition known
as pseudohypoaldosteronism lO• II.
Imaging' studies as ultrasound (US), computed
tomography (CT) scan and magnetic resonance
image (MRI) of the abdomen/pelvis can aid in
identifying the uterus (Figure 4) and gonads. The latter
however may not be easily visualised. Genitogram
needs to be done to identify the anatomy of the
genitourinary system (Figure ~nd 5) that is important
for future surgical correction of the external genitalia.
Cliloroplasty is usually performed in infancy but not
performed in patient 1 due to poor understanding of
the condition by the parents. Vaginoplasty with division
of the fused labial folds can be delayed until puberty.
Close regular evaluation and dosage adjustment
of hormonal treatment especially glucocorticoids is
needed for a successful treatment. Under dosage of
glucocorticoids cause virilisation while over dosage
causes hypertension (patient 1) and short stature as an
adult.
CONCLUSION
Molecular studies for SRY gene is one of the
tools for sex confinnat.Kln in addition to hormonal and
imaging studies in the evaluation of AG. Determination
of SRY gene may be helpful in sex determination and
gender assignment. It is a rapid and reliable technique
and will help the clinicians in making the right
management decision. Regular medical assessment and
lllonlwllJlg ul' ueaLJJlclil i~ U1L- kL-y tv rhe ~uccclJu[ul
management of CAHIAG.
Molecular studies have enabled us to confmn
the sex of the 3 patients presenting with AG. It has aided
us in family counseling and further management
including the surgical correction of the external genitalia.
as in patient 1 and 2. Furthermore we could counsel
the parents with regards to sex reassignment in our
second patient and prevent future virilisation and gender
crisis. As for patient 3, we were able to counsel the
parents who are anxious about the true gender of their
baby and the fact that she need not receive life-long
hormonal therapy. In the 3 patients that we m~naged,
the parents were content to have the problem rectified,
better understanding of the condition and to accept the
appropriate management.
In our experience with the cases ofAG, we noted
that hormonal investigations should be done to confirm
CAH and to include the molecular analyses as a
complementary tool in the battery of investigations.
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